1 Report Overview
1.1 Study Scope
1.2 Market Analysis By Cell Therapy
1.2.1 Global Cell and Gene Therapy Manufacturing Services Market Size Growth Rate By Cell Therapy: 2017 VS 2021 VS 2028
1.2.2 Allogeneic
1.2.3 Autologous
1.2.4 Viral Vector
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Manufacturing Services Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Oncology Diseases
1.3.3 Cardiovascular Diseases
1.3.4 Orthopedic Diseases
1.3.5 Ophthalmology Diseases
1.3.6 Infectious Diseases
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Manufacturing Services Market Perspective (2017-2028)
2.2 Cell and Gene Therapy Manufacturing Services Growth Trends by Region
2.2.1 Cell and Gene Therapy Manufacturing Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell and Gene Therapy Manufacturing Services Historic Market Size by Region (2017-2022)
2.2.3 Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Region (2023-2028)
2.3 Cell and Gene Therapy Manufacturing Services Market Dynamics
2.3.1 Cell and Gene Therapy Manufacturing Services Industry Trends
2.3.2 Cell and Gene Therapy Manufacturing Services Market Drivers
2.3.3 Cell and Gene Therapy Manufacturing Services Market Challenges
2.3.4 Cell and Gene Therapy Manufacturing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Manufacturing Services Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Manufacturing Services Players by Revenue (2017-2022)
3.1.2 Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Players (2017-2022)
3.2 Global Cell and Gene Therapy Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell and Gene Therapy Manufacturing Services Revenue
3.4 Global Cell and Gene Therapy Manufacturing Services Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Manufacturing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Manufacturing Services Revenue in 2021
3.5 Cell and Gene Therapy Manufacturing Services Key Players Head office and Area Served
3.6 Key Players Cell and Gene Therapy Manufacturing Services Product Solution and Service
3.7 Date of Enter into Cell and Gene Therapy Manufacturing Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Manufacturing Services Breakdown Data by Type
4.1 Global Cell and Gene Therapy Manufacturing Services Historic Market Size by Type (2017-2022)
4.2 Global Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Type (2023-2028)
5 Cell and Gene Therapy Manufacturing Services Breakdown Data by Application
5.1 Global Cell and Gene Therapy Manufacturing Services Historic Market Size by Application (2017-2022)
5.2 Global Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
6.2 North America Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
6.3 North America Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
7.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
7.3 Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
8.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
8.3 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
9.2 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
9.3 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
10.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
10.3 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Detail
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Introduction
11.2.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.2.5 Merck KGaA Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Detail
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Introduction
11.3.4 Charles River Laboratories Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.3.5 Charles River Laboratories Recent Development
11.4 Lonza
11.4.1 Lonza Company Detail
11.4.2 Lonza Business Overview
11.4.3 Lonza Cell and Gene Therapy Manufacturing Services Introduction
11.4.4 Lonza Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.4.5 Lonza Recent Development
11.5 Catalent
11.5.1 Catalent Company Detail
11.5.2 Catalent Business Overview
11.5.3 Catalent Cell and Gene Therapy Manufacturing Services Introduction
11.5.4 Catalent Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.5.5 Catalent Recent Development
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Detail
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Introduction
11.6.4 WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.6.5 WuXi AppTec Recent Development
11.7 Takara Bio Inc
11.7.1 Takara Bio Inc Company Detail
11.7.2 Takara Bio Inc Business Overview
11.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Introduction
11.7.4 Takara Bio Inc Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.7.5 Takara Bio Inc Recent Development
11.8 Nikon Corporation
11.8.1 Nikon Corporation Company Detail
11.8.2 Nikon Corporation Business Overview
11.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Introduction
11.8.4 Nikon Corporation Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.8.5 Nikon Corporation Recent Development
11.9 FUJIFILM Holdings Corporation
11.9.1 FUJIFILM Holdings Corporation Company Detail
11.9.2 FUJIFILM Holdings Corporation Business Overview
11.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Introduction
11.9.4 FUJIFILM Holdings Corporation Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.9.5 FUJIFILM Holdings Corporation Recent Development
11.10 F. Hoffmann-La Roche
11.10.1 F. Hoffmann-La Roche Company Detail
11.10.2 F. Hoffmann-La Roche Business Overview
11.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Introduction
11.10.4 F. Hoffmann-La Roche Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.10.5 F. Hoffmann-La Roche Recent Development
11.11 Oxford Biomedica Plc
11.11.1 Oxford Biomedica Plc Company Detail
11.11.2 Oxford Biomedica Plc Business Overview
11.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Introduction
11.11.4 Oxford Biomedica Plc Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.11.5 Oxford Biomedica Plc Recent Development
11.12 Cell and Gene Therapy Catapult
11.12.1 Cell and Gene Therapy Catapult Company Detail
11.12.2 Cell and Gene Therapy Catapult Business Overview
11.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Introduction
11.12.4 Cell and Gene Therapy Catapult Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.12.5 Cell and Gene Therapy Catapult Recent Development
11.13 The Discovery Labs LLC
11.13.1 The Discovery Labs LLC Company Detail
11.13.2 The Discovery Labs LLC Business Overview
11.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Introduction
11.13.4 The Discovery Labs LLC Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.13.5 The Discovery Labs LLC Recent Development
11.14 RoslinCT
11.14.1 RoslinCT Company Detail
11.14.2 RoslinCT Business Overview
11.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Introduction
11.14.4 RoslinCT Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.14.5 RoslinCT Recent Development
11.15 JRS PHARMA
11.15.1 JRS PHARMA Company Detail
11.15.2 JRS PHARMA Business Overview
11.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Introduction
11.15.4 JRS PHARMA Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.15.5 JRS PHARMA Recent Development
11.16 FinVector
11.16.1 FinVector Company Detail
11.16.2 FinVector Business Overview
11.16.3 FinVector Cell and Gene Therapy Manufacturing Services Introduction
11.16.4 FinVector Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.16.5 FinVector Recent Development
11.17 ABL
11.17.1 ABL Company Detail
11.17.2 ABL Business Overview
11.17.3 ABL Cell and Gene Therapy Manufacturing Services Introduction
11.17.4 ABL Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.17.5 ABL Recent Development
11.18 Resilience
11.18.1 Resilience Company Detail
11.18.2 Resilience Business Overview
11.18.3 Resilience Cell and Gene Therapy Manufacturing Services Introduction
11.18.4 Resilience Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.18.5 Resilience Recent Development
11.19 BioCentriq
11.19.1 BioCentriq Company Detail
11.19.2 BioCentriq Business Overview
11.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Introduction
11.19.4 BioCentriq Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.19.5 BioCentriq Recent Development
11.20 Porton Biopharma Limited
11.20.1 Porton Biopharma Limited Company Detail
11.20.2 Porton Biopharma Limited Business Overview
11.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Introduction
11.20.4 Porton Biopharma Limited Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.20.5 Porton Biopharma Limited Recent Development
11.21 Andelyn Biosciences
11.21.1 Andelyn Biosciences Company Detail
11.21.2 Andelyn Biosciences Business Overview
11.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Introduction
11.21.4 Andelyn Biosciences Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.21.5 Andelyn Biosciences Recent Development
11.22 Commercializing Living Therapies
11.22.1 Commercializing Living Therapies Company Detail
11.22.2 Commercializing Living Therapies Business Overview
11.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Introduction
11.22.4 Commercializing Living Therapies Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.22.5 Commercializing Living Therapies Recent Development
11.23 Vibalogics
11.23.1 Vibalogics Company Detail
11.23.2 Vibalogics Business Overview
11.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Introduction
11.23.4 Vibalogics Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.23.5 Vibalogics Recent Development
11.24 Anemocyte Srl
11.24.1 Anemocyte Srl Company Detail
11.24.2 Anemocyte Srl Business Overview
11.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Introduction
11.24.4 Anemocyte Srl Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.24.5 Anemocyte Srl Recent Development
11.25 ElevateBio
11.25.1 ElevateBio Company Detail
11.25.2 ElevateBio Business Overview
11.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Introduction
11.25.4 ElevateBio Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.25.5 ElevateBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
